NEW YORK (GenomeWeb) – Pacific Biosciences announced today that it has priced an underwritten public offering of 15.4 million shares of common stock at $3.10 per share.

PacBio has also granted the underwriters a 30-day option to purchase up to an additional 2.3 million shares. After deducting the underwriting discount and expenses, the company expects to raise net proceeds of approximately $45.9 million, assuming the underwriter's option to purchase additional shares is not exercised.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.